Worldwide Clinical Trials’ Clinical Pharmacology Unit Earns Accreditation from the College of American Pathologists
Worldwide Clinical Trials , a leading global, full-service contract research organization (CRO), has announced its Early Phase Clinical Pharmacology Unit (CPU) has been awarded accreditation from the College of American Pathologists ( CAP ).
- Worldwide Clinical Trials , a leading global, full-service contract research organization (CRO), has announced its Early Phase Clinical Pharmacology Unit (CPU) has been awarded accreditation from the College of American Pathologists ( CAP ).
- To achieve accreditation, the clinic passed a rigorous evaluation process that involved an in-depth inspection of its clinical laboratory facilities, equipment, processes, quality control measures, and personnel qualifications – conducted onsite by CAP inspectors.
- “The College of American Pathologists is known for the highest standards in laboratory quality,” said Mike Mencer , Executive Vice President and General Manager, Early Phase.
- Worldwide opened the Bioanalytical Center of Excellence in June 2022 in Austin, Texas, to support its Early Phase development and expansion.